about
ARNI: A New Paradigm for the Treatment of Heart Failure in Taiwan?Application and impact of run-in studies.Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Critical Questions about PARADIGM-HF and the Future
@ast
Critical Questions about PARADIGM-HF and the Future
@en
Critical Questions about PARADIGM-HF and the Future
@nl
type
label
Critical Questions about PARADIGM-HF and the Future
@ast
Critical Questions about PARADIGM-HF and the Future
@en
Critical Questions about PARADIGM-HF and the Future
@nl
prefLabel
Critical Questions about PARADIGM-HF and the Future
@ast
Critical Questions about PARADIGM-HF and the Future
@en
Critical Questions about PARADIGM-HF and the Future
@nl
P2860
P356
P1476
Critical Questions about PARADIGM-HF and the Future
@en
P2093
Chen-Huan Chen
P2860
P304
P356
10.6515/ACS20151120A
P407
P577
2016-07-01T00:00:00Z